<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:hpo ids='HP_0000952'>jaundice</z:hpo> leading to <z:hpo ids='HP_0001343'>kernicterus</z:hpo> or <z:hpo ids='HP_0011420'>death</z:hpo> in the newborn is the most devastating consequence of <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphate dehydrogenase (EC 1.1.1.49; G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>We asked whether the TA repeat promoter polymorphism in the gene for uridinediphosphoglucuronate glucuronosyltransferase 1 (EC 2.4.1.17; UDPGT1), associated with benign <z:hpo ids='HP_0000952'>jaundice</z:hpo> in adults (<z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e>), increases the incidence of <z:hpo ids='HP_0003265'>neonatal hyperbilirubinemia</z:hpo> in <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G-6-PD deficiency</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>DNA from term neonates was analyzed for UDPGT1 polymorphism (<z:mpath ids='MPATH_458'>normal</z:mpath> homozygotes, heterozygotes, variant homozygotes), and for G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> Mediterranean deficiency </plain></SENT>
<SENT sid="3" pm="."><plain>The variant UDPGT1 promoter allele frequency was similar in G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient and <z:mpath ids='MPATH_458'>normal</z:mpath> neonates </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty (22.9%) G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> deficient neonates developed serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> &gt;/= 257 micromol/liter, vs. 22 (9.2%) <z:mpath ids='MPATH_458'>normals</z:mpath> (P = 0.0005) </plain></SENT>
<SENT sid="5" pm="."><plain>Of those with the <z:mpath ids='MPATH_458'>normal</z:mpath> homozygous UDPGT1 genotype, the incidence of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> was similar in G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficients and controls (9.7% and 9.9%) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, in the G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates, those with the heterozygous or homozygous variant UDPGT1 genotype had a higher incidence of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> than corresponding controls (heterozygotes: 31.6% vs. 6.7%, P &lt; 0.0001; variant homozygotes: 50% vs. 14.7%, P = 0.02) </plain></SENT>
<SENT sid="7" pm="."><plain>Among G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient infants the incidence of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> was greater in those with the heterozygous (31.6%, P = 0.006) or variant homozygous (50%, P = 0.003) UDPGT1 genotype than in <z:mpath ids='MPATH_458'>normal</z:mpath> homozygotes </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, among those <z:mpath ids='MPATH_458'>normal</z:mpath> for G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>, the UDPGT1 polymorphism had no significant effect (heterozygotes: 6.7%; variant homozygotes: 14.7%) </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, neither <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G-6-PD deficiency</z:e> nor the variant UDPGT1 promoter, alone, increased the incidence of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo>, but both in combination did </plain></SENT>
<SENT sid="10" pm="."><plain>This gene interaction may serve as a paradigm of the interaction of benign genetic polymorphisms in the causation of disease </plain></SENT>
</text></document>